愛康醫療(01789.HK)預計上半年盈利同比減少35%
格隆匯7月23日丨愛康醫療(01789.HK)公佈,相較截至2020年6月30日止六個月的收入,董事會預期截至2021年6月30日止六個月的收入將錄得約10%的適度跌幅。
相較截至2020年6月30日止六個月的淨溢利,董事會預期截至2021年6月30日止六個月的淨溢利將錄得約35%的顯著跌幅。
截至2021年6月30日止六個月的收入跌幅主要歸因於現行全國關節植入物帶量採購政策導致價格趨勢存在不確定性,經銷商(即本集團客户)減少關節植入物進貨所致。
截至2021年6月30日止六個月的淨溢利跌幅主要歸因於上述收入下跌以及市場推廣開支增加(因恢復市場推廣活動所致)及支付社會保險所致。於2020年,由於新冠疫情影響,公司大部分市場推廣活動取消,政府也減少或豁免部分應付員工社會保險款項。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.